About one in eight women will develop invasive breast cancer at some point.

In some women these cells become an invasive breast cancer.

Two types account for about 95% of invasive breast cancer.

During 17 years of follow-up 268 women developed invasive breast cancer.

During the study period, 7,690 cases of invasive breast cancer were diagnosed.

But it did reduce the risk of invasive breast cancer by 44 percent over 5.6 years, compared with women not taking the drug.

This is not invasive breast cancer, the kind that kills.

This type accounts for about 10% of invasive breast cancers.

About 25% of women diagnosed with this condition develop invasive breast cancer.

About one in eight cases of invasive breast cancer are found in women under 45.

During that period, roughly 7,700 of the women enrolled developed invasive breast cancer.

All the women had invasive breast cancer, and their cancers were completely removed before treatment.

Kalager and her colleagues looked only at invasive breast cancer.

The researchers found that in the first two years, the rate of invasive breast cancer among whites was stable.

One in eight U.S. women are expected to develop invasive breast cancer during their lives.

In all, the study participants reported 8,772 cases of invasive breast cancer during that timeframe.

She ran through a nest egg while fighting invasive breast cancer seven years ago, her friends said.

Fourteen were diagnosed with invasive breast cancer, they are still receiving treatment.

Earlier in 2008, Gujral was treated for early stage, invasive breast cancer.

For the cohort study, 1,684 women were recruited within 12 months of being diagnosed with invasive breast cancer.

The chance of developing invasive breast cancer at some time in a woman's life is a little less than one in eight (12%).

About 182,460 women in the United States will be diagnosed with invasive breast cancer this year.

After about three years, there were 11 cases of invasive breast cancer among those on the drug versus 32 among the others.

Choosing the most appropriate operation for early invasive breast cancer Guideline 4.

By itself, it doesn't harm a woman, but in some cases it goes on to invasive breast cancer.